版本:
中国

BRIEF-Kuros Biosciences appoints Ivan Cohen-Tanugi as CEO

April 13 Kuros Biosciences AG:

* Announces CEO succession

* Ivan Cohen-Tanugi has been appointed Chief Executive Officer with effect as of April 13, 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐